$FRFS DD - worth reading: Hornet Driver Thursday,

New Post Public Reply Private Reply Replies (0) Message Board
guidelines
272
$FRFS DD - worth reading: Hornet Driver Thursday, 05/31/18 11:41:46 AM

Quote, "I just don't think we'll be seeing market wire PR until the symbol/name change goes in effect. "

BINGO !! 100% CORRECT. I've tried to state the same thing many times.

GIFA has to be careful as all get-out to NOT release any formal U.S. PR that can emphatically state that, they GIFA and what "was" FRFS Firefish (PAST TENSE and no longer exits) are now "rolled into" being one and the same, aka what a reverse merger is and does... especially as far as the FRFS shares are concerned. They could blow their entire FINRA approval process and filing.

They've been using their foreign papers to "HINT" using carefully chosen words such as "ENTERING THE U.S. STOCK MARKET" but one has NEVER, EVER, EVER seen them even hint or use the words "FRFS" or "Firefish" etc. As they CAN NOT DO THAT until the reverse merger into the shell is completed.

They're DOING IT BY THE BOOK as they should be, I'm sure under the advice of their U.S. based securities attorney, a very experienced dude, a professor at securities law, etc

Thus, the "hint" appeared to be, IMO, they "thought" they were about to wrap-up the FINRA filing and get it made "official" and most likely this "tax office share transfer" crap happened, else, as another poster stated, FINRA may have just asked for one more piece of paper or whatever- it happens all the time.

NOTHING IS LATE or even supposedly "taking a long time" (as is being FALSELY STATED HERE THIS AM by people completely IGNORANT of how a reverse merger works or what it even means)....they, GIFA, they started this process in late 2017 and it's only end of May....NOTHING unusual about a large reverse merger FOR A FOREIGN OFF-SHORE company (or any company) reverse merger taking EASILY 6 months to 9 months to even 1 yr is not surprising....

Seen it many times and on companies that were VAPOR-WARE...without any real assets or anything...most recent being the Chinese "car company" which was LITERALLY a one man show for all intents and purposes with no real factory, not much of any assets, no staff really, no employees yet- just a pipe dream and a dude merging a shell, and it was about a NINE MONTH deal....with FINRA....but he got it approved and got it done....

GIFA is just fine...expect some BUYING MAYBE LATER TODAY as the dust settles...it rose 120% IN ONE DAY on even a "hint" of the reverse merger being completed...and that is still in-process....just need FINRA DAILY LIST and it's gonna blow like a 3 megaton nuke....it hasn't even fully re-traced all the gains of the past few days...it's still NET UP...even on this pull-back....ALL IS COOL....PATIENCE.....
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation Alerts for Spyre Therapeutics Investors Amid Concerns

Updated Category News Views 143

Investigation of Claims for Spyre Therapeutics Investors Pomerantz LLP is currently investigating claims on behalf of investors of Spyre Therapeutics, Inc. (NASDAQ: SYRE). The firm seeks to understand whether Spyre and its executives have potentially engaged in any unlawful business practices, specifically concerning securities fraud. Understanding the Securities Concerns...

Continue Reading
Natixis CIB's Pioneering Project Financing for Infrastructure

Updated Category News Views 126

Natixis CIB's Role in Groundbreaking Project Financing Natixis Corporate & Investment Banking (Natixis CIB) has taken a significant step in enhancing infrastructure development by serving as Joint Bookrunner and Joint Lead Arranger for a remarkable $281 million project financing. This financing initiative will support Ruta del Este, a concessionaire formed by ISA Vías to...

Continue Reading
Finch Therapeutics Moves to Delist from Nasdaq Amid Challenges

Updated Category News Views 177

Finch Therapeutics Plans Delisting from Nasdaq Finch Therapeutics Group, Inc. (Nasdaq: FNCH) has recently announced its decision to delist from The Nasdaq Stock Market, LLC. This move is part of a broader strategy aimed at navigating current market challenges and optimizing operational efficiency. The company is a leader in microbiome technology, boasting a strong...

Continue Reading
ModivCare: Exploring Recent Developments and Stockholder Rights

Updated Category News Views 269

Investigating the Latest Events Surrounding ModivCare Recent events surrounding ModivCare, Inc. have drawn considerable attention from the investor community and law firms alike. This scrutiny comes after a class action lawsuit from long-term shareholders, alleging the company's management may have misled investors about its ability to manage its financial health during a...

Continue Reading
Investors in Avantor, Inc. Urged to Act Before Key Deadline

Updated Category News Views 157

A Call to Action for Avantor, Inc. Investors Investors in Avantor, Inc. should take heed of an essential notification regarding a securities class action. As a market participant interested in Avantor, Inc. (NYSE: AVTR), your involvement could be crucial. This class action centers around stock purchases made during a specific timeframe that is intended to hold the company...

Continue Reading